Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer Among younger men with prostate ...
The author(s) indicated no potential conflicts of interest. Corresponding author: Anthony V. D'Amico, MD, PhD, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115; e-mail: [email protected].
Hosted on MSN
At 10 years, stereotactic body radiation therapy comparable to surgery for early-stage lung cancer
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...
As part of the “Speaking Out” series, a radiation oncologist discusses the benefits of MRI-guided stereotactic body radiation therapy. Dr. Matthew Solhjem, a radiation oncologist with Providence ...
SBRT combined with Nexavar improved median OS to 15.8 months versus 12.3 months with Nexavar alone in patients with advanced HCC. Median PFS increased from 5.5 months with Nexavar alone to 9.2 months ...
A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 patients with small cell lung cancer and brain metastases, finding they ...
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with severe abnormal heart rhythms that can no longer be controlled with medication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback